Summary
President Donald Trump is promoting his efforts to lower prescription drug prices through new deals with drug companies and the launch of a direct sales platform called TrumpRx. However, many experts believe that most Americans will not see significant changes in what they pay for medications. The White House's strategy includes making health care a key focus in upcoming elections.
Key Facts
- President Trump has made agreements with drug companies to offer more discounts and tie drug prices to those in other countries.
- TrumpRx is a new platform selling drugs directly to consumers at lower prices.
- Most patients get prescriptions through insurance, so they may not benefit from lower list prices.
- Some drugs on TrumpRx are already or will soon be available as cheaper generics.
- Experts think many drug companies may delay new product launches to avoid lower U.S. prices.
- A notable exception is a deal with Eli Lilly and Novo Nordisk, expanding Medicare coverage for anti-obesity drugs.
- Although Trump has addressed drug pricing, experts say most Americans won't notice significant savings.
